Editorial: Modulating lymphatic vascular growth in disease: current and potential pharmacological approaches for prevention and treatment, Volume II

Natalie L Trevaskis; Ines Martinez-Corral; Melissa García-Caballero

doi:10.3389/fphar.2023.1224414

Editorial: Modulating lymphatic vascular growth in disease: current and potential pharmacological approaches for prevention and treatment, Volume II

Front Pharmacol. 2023 Jul 4:14:1224414. doi: 10.3389/fphar.2023.1224414. eCollection 2023.

Authors

Natalie L Trevaskis¹, Ines Martinez-Corral², Melissa García-Caballero^{3

4}

Affiliations

¹ Department of Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.
² Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, Inserm UMR-S1172, University of Lille, Inserm, CHU Lille, Lille, France.
³ Department of Molecular Biology and Biochemistry, Faculty of Sciences, University of Málaga, Andalucía Tech, Málaga, Spain.
⁴ IBIMA (Biomedical Research Institute of Málaga)-Plataforma BIONAND, Málaga, Spain.

No abstract available

Keywords: cancer; lymphatic vessels; lymphedema; models; treatment.

Publication types

Editorial

Grants and funding

This study was supported by the Beatriz Galindo Programme from the Spanish Ministry of Education and Professional Formation, Fundación Científica AECC (LABAE211691GARC), the Instituto de Salud Carlos III (ISCIII) through the project “PI21/00653” and co-funded by the European Union (MG-C), BBVA Foundation (BZG10931) and L’ORÉAL-UNESCO For Women in Science.